Evidence map›Paper›PMID 22734612›Full record

ArticleOrphanet journal of rare diseases2012

Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.

Thomas J Jaworek, Tasleem Kausar, Shannon M Bell, Nabeela Tariq, Muhammad Imran Maqsood, Asma Sohail, Muhmmmad Ali, Furhan Iqbal, Shafqat Rasool, Saima Riazuddin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Dopachrome tautomerase variants in patients with oculocutaneous albinism.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  11. Identification of Hearing Loss-Associated Variants ofBioMed research international · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Homozygous Variant in ARL3 Causes Autosomal Recessive Cone Rod Dystrophy.Investigative ophthalmology & visual science · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Thomas J JaworekDivision of Pediatric Ophthalmology, Cincinnati Children's Hospital Research Foundation, Cincinnati, OH 45229, USA.
Tasleem Kausar
Shannon M Bell
Nabeela Tariq
Muhammad Imran Maqsood
Asma Sohail
Muhmmmad Ali
Furhan Iqbal
Shafqat Rasool
Saima Riazuddin
Rehan S Shaikh
Zubair M Ahmed
Bahauddin Zakariya University · PKCincinnati Children's Hospital Medical Center · USHospital Research Foundation · AUNishtar Medical College and Hospital · PK

Funding

Identifying Genes for Non-syndromic Recessive Deafness-A Collaborative StudyR01DC011803 · NIDCD · UNIVERSITY OF MARYLAND BALTIMORE · PI RIAZUDDIN, SAIMA · 2012 to 2016
$1.6M
MOLECULAR GENETICS OF USHER SYNDROME TYPE IR00DC009287 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI AHMED, ZUBAIR M. · 2009 to 2011
$732k
Intramural NIH HHSNIDCD NIH HHS R00-DC009287-03NIDCD NIH HHS R01 DC011803
6 · The paper itself

Abstract

backgroundOculocutaneous albinism (OCA) is caused by a group of genetically heterogeneous inherited defects that result in the loss of pigmentation in the eyes, skin and hair. Mutations in the TYR, OCA2, TYRP1 and SLC45A2 genes have been shown to cause isolated OCA. No comprehensive analysis has been conducted to study the spectrum of OCA alleles prevailing in Pakistani albino populations.

methodsWe enrolled 40 large Pakistani families and screened them for OCA genes and a candidate gene, SLC24A5. Protein function effects were evaluated using in silico prediction algorithms and ex vivo studies in human melanocytes. The effects of splice-site mutations were determined using an exon-trapping assay.

resultsScreening of the TYR gene revealed four known (p.Arg299His, p.Pro406Leu, p.Gly419Arg, p.Arg278*) and three novel mutations (p.Pro21Leu, p.Cys35Arg, p.Tyr411His) in ten families. Ex vivo studies revealed the retention of an EGFP-tagged mutant (p.Pro21Leu, p.Cys35Arg or p.Tyr411His) tyrosinase in the endoplasmic reticulum (ER) at 37°C, but a significant fraction of p.Cys35Arg and p.Tyr411His left the ER in cells grown at a permissive temperature (31°C). Three novel (p.Asp486Tyr, p.Leu527Arg, c.1045-15 T > G) and two known mutations (p.Pro743Leu, p.Ala787Thr) of OCA2 were found in fourteen families. Exon-trapping assays with a construct containing a novel c.1045-15 T > G mutation revealed an error in splicing. No mutation in TYRP1, SLC45A2, and SLC24A5 was found in the remaining 16 families. Clinical evaluation of the families segregating either TYR or OCA2 mutations showed nystagmus, photophobia, and loss of pigmentation in the skin or hair follicles. Most of the affected individuals had grayish-blue colored eyes.

conclusionsOur results show that ten and fourteen families harbored mutations in the TYR and OCA2 genes, respectively. Our findings, along with the results of previous studies, indicate that the p.Cys35Arg, p.Arg278* and p.Gly419Arg alleles of TYR and the p.Asp486Tyr and c.1045-15 T > G alleles of OCA2 are the most common causes of OCA in Pakistani families. To the best of our knowledge, this study represents the first documentation of OCA2 alleles in the Pakistani population. A significant proportion of our cohort did not have mutations in known OCA genes. Overall, our study contributes to the development of genetic testing protocols and genetic counseling for OCA in Pakistani families.

Indexed as

AdolescentAdultAlbinism, OculocutaneousCells, CulturedChildExonsFemaleFluorescent DyesHumansMaleMiddle AgedPakistanPedigreePhenotypePolymerase Chain ReactionYoung AdultFluorescent Dyes

Identifiers

PMID22734612
PMCPMC3537634
OpenAlexW2107510064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.